Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KALETRA for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 36 adverse event reports in the FDA FAERS database where KALETRA was used for Maternal exposure timing unspecified.

Most Reported Side Effects for KALETRA

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 52 25.0% 14 13
Exposure during pregnancy 20 9.6% 0 2
Abortion spontaneous 19 9.1% 1 0
Premature baby 14 6.7% 6 4
Anaemia 11 5.3% 5 6
Kaposi's sarcoma 8 3.9% 0 0
Abortion induced 7 3.4% 3 0
Metabolic acidosis 7 3.4% 7 3
Coronary artery disease 6 2.9% 0 4
Death 6 2.9% 6 1
Drug interaction 6 2.9% 0 5
Hypotonia 6 2.9% 6 2
Status epilepticus 6 2.9% 0 6
Stillbirth 6 2.9% 1 0
Vomiting 6 2.9% 0 5

Other Indications for KALETRA

Hiv infection (122) Antiretroviral therapy (19) Product used for unknown indication (13)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

KALETRA Full Profile All Maternal exposure timing unspecified Drugs KALETRA Demographics KALETRA Timeline